{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:23:00Z","timestamp":1791091380793,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Jiangsu Province\u2019s Scientific and Technological Supporting Program","award":["BL2012058"],"award-info":[{"award-number":["BL2012058"]}]}],"content-domain":{"domain":["jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.jocn.2013.10.040","type":"journal-article","created":{"date-parts":[[2014,2,6]],"date-time":"2014-02-06T20:45:48Z","timestamp":1391719548000},"page":"1283-1287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Neuroprotection with erythropoietin in preterm and\/or low birth weight infants"],"prefix":"10.1016","volume":"21","author":[{"given":"Jie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2013.10.040_b0005","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(06)68587-5","article-title":"1year after the Lancet Neonatal Survival Series\u2014was the call for action heard?","volume":"367","author":"Lawn","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2013.10.040_b0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0140-6736(08)60074-4","article-title":"Epidemiology and causes of preterm birth","volume":"371","author":"Goldenberg","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2013.10.040_b0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/adc.2008.146282","article-title":"Very preterm children show impairments across multiple neurodevelopmental domains by age 4years","volume":"94","author":"Woodward","year":"2009","journal-title":"Arch Dis Child-Fetal Neonatal Ed"},{"key":"10.1016\/j.jocn.2013.10.040_b0020","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1469-8749.2007.00325.x","article-title":"Developmental coordination disorder at 8years of age in a regional cohort of extremely-low-birthweight or very preterm infants","volume":"49","author":"Davis","year":"2007","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.jocn.2013.10.040_b0025","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1542\/peds.2004-0221","article-title":"Improved survival rates with increased neurodevelopmental disability for extremely low birth weight infants in the 1990s","volume":"115","author":"Wilson-Costello","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.jocn.2013.10.040_b0030","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1542\/peds.113.4.781","article-title":"Center differences and outcomes of extremely low birth weight infants","volume":"113","author":"Vohr","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jocn.2013.10.040_b0035","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/S0140-6736(10)60992-0","article-title":"Erythropoietin: not just about erythropoiesis","volume":"375","author":"Ghezzi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2013.10.040_b0040","first-page":"CD004863","article-title":"Early erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants","volume":"19","author":"Ohlsson","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jocn.2013.10.040_b0045","doi-asserted-by":"crossref","first-page":"e805","DOI":"10.1542\/peds.2009-1853","article-title":"Can erythropoietin improve developmental outcomes for preterm infants?","volume":"124","author":"McPherson","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.jocn.2013.10.040_b0050","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/sj.jp.7200244","article-title":"Neurodevelopmental outcome of prematurely born children treated with recombinant human erythropoietin in infancy","volume":"19","author":"Newton","year":"1999","journal-title":"J Perinatol"},{"key":"10.1016\/j.jocn.2013.10.040_b0055","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1542\/peds.2003-1129-L","article-title":"Neurodevelopmental outcome and growth at 18 to 22months\u2019 corrected age in extremely low birth weight infants treated with early erythropoietin and iron","volume":"114","author":"Ohls","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.jocn.2013.10.040_b0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0029-7844(95)00386-X","article-title":"A United States national reference for fetal growth","volume":"87","author":"Alexander","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jocn.2013.10.040_b0065","doi-asserted-by":"crossref","first-page":"e635","DOI":"10.1542\/peds.2005-3186","article-title":"Erythropoietin concentrations and neurodevelopmental outcome in preterm infants","volume":"118","author":"Bierer","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.jocn.2013.10.040_b0070","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1542\/peds.2007-2591","article-title":"An approach to using recombinant erythropoietin for neuroprotection in very preterm infants","volume":"122","author":"Fauchere","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jocn.2013.10.040_b0075","first-page":"586","article-title":"Early use of recombinant human erythropoietin promotes neurobehavioral development in preterm infants","volume":"10","author":"He","year":"2008","journal-title":"Zhongguo Dang Dai Er Ke Za Zhi"},{"key":"10.1016\/j.jocn.2013.10.040_b0080","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1542\/peds.2007-2711","article-title":"A phase I\/II trial of high-dose erythropoietin in extremely low birth weight infants: pharmacokinetics and safety","volume":"122","author":"Juul","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.jocn.2013.10.040_b0085","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/ana.21977","article-title":"Erythropoietin improves neurodevelopmental outcome of extremely preterm infants","volume":"67","author":"Neubauer","year":"2010","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jocn.2013.10.040_b0090","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1182\/blood.V76.1.31.31","article-title":"Human erythropoietin receptor: cloning, expression, and biologic characterization","volume":"76","author":"Jones","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.jocn.2013.10.040_b0095","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/cne.22020","article-title":"Erythropoietin receptor expression is concordant with erythropoietin but not with common \u03b2 chain expression in the rat brain throughout the life span","volume":"514","author":"Sanchez","year":"2009","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.jocn.2013.10.040_b0100","first-page":"651","article-title":"Focused Conference Group: P01\u2013clinical pharmacology in the emerging countries study on protection effect of erythropoietin on newborn rats with hypoxic-ischemic brain damage","volume":"107","author":"Wang","year":"2010","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.jocn.2013.10.040_b0105","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.devbrainres.2005.08.006","article-title":"Protective effects of erythropoietin against ethanol-induced apoptotic neurodegenaration and oxidative stress in the developing C57BL\/6 mouse brain","volume":"160","author":"Kumral","year":"2005","journal-title":"Dev Brain Res"},{"key":"10.1016\/j.jocn.2013.10.040_b0110","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1203\/PDR.0b013e31819d90c8","article-title":"Microarray analysis of high-dose recombinant erythropoietin treatment of unilateral brain injury in neonatal mouse hippocampus","volume":"65","author":"Juul","year":"2009","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jocn.2013.10.040_b0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1203\/PDR.0b013e3181e67d02","article-title":"Short-term effect of erythropoietin on brain lesions and aquaporin-4 expression in a hypoxic-ischemic neonatal rat model assessed by magnetic resonance diffusion weighted imaging and immunohistochemistry","volume":"68","author":"Brissaud","year":"2010","journal-title":"Pediatr Res"},{"key":"10.1016\/j.jocn.2013.10.040_b0120","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3171\/2010.5.PEDS1032","article-title":"Postnatal erythropoietin treatment mitigates neural cell loss after systemic prenatal hypoxic-ischemic injury: laboratory investigation","volume":"6","author":"Mazur","year":"2010","journal-title":"J Neurosurg Pediatr"},{"key":"10.1016\/j.jocn.2013.10.040_b0125","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1111\/j.1471-4159.2004.02769.x","article-title":"The nonerythropoietic asialoerythropoietin protects against neonatal hypoxia-ischemia as potently as erythropoietin","volume":"91","author":"Wang","year":"2004","journal-title":"J Neurochem"},{"key":"10.1016\/j.jocn.2013.10.040_b0130","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ijdevneu.2010.12.007","article-title":"Erythropoietin for neonatal brain injury: opportunity and challenge","volume":"29","author":"Xiong","year":"2011","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/j.jocn.2013.10.040_b0135","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/jnen\/62.3.228","article-title":"The pleiotropic effects of erythropoietin in the central nervous system","volume":"62","author":"Buemi","year":"2003","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.jocn.2013.10.040_b0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1651-2227.2002.tb02904.x","article-title":"Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage","volume":"91","author":"Juul","year":"2002","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.jocn.2013.10.040_b0145","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/1073858403259187","article-title":"Erythropoietin as a tissue-protective cytokine in brain injury: what do we know and where do we go?","volume":"10","author":"Grasso","year":"2004","journal-title":"Neuroscientist"},{"key":"10.1016\/j.jocn.2013.10.040_b0150","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1528-1167.2006.00900.x","article-title":"Effects of a single dose of erythropoietin on subsequent seizure susceptibility in rats exposed to acute hypoxia at P10","volume":"48","author":"Mikati","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.jocn.2013.10.040_b0155","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000232558","article-title":"Erythropoietin sustains cognitive function and brain volume after neonatal stroke","volume":"31","author":"Gonzalez","year":"2009","journal-title":"Dev Neurosci"},{"key":"10.1016\/j.jocn.2013.10.040_b0160","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000096969","article-title":"Safety of high-dose recombinant erythropoietin in a neonatal rat model","volume":"91","author":"McPherson","year":"2007","journal-title":"Neonatology"},{"key":"10.1016\/j.jocn.2013.10.040_b0165","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S1726-4901(08)70154-0","article-title":"Conditions associated with hypertension in a high-risk premature infant","volume":"71","author":"Chen","year":"2008","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/j.jocn.2013.10.040_b0170","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1182\/blood-2002-09-2814","article-title":"Hemostasis and coagulation at a hematocrit level of 0.85: functional consequences of erythrocytosis","volume":"101","author":"Shibata","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.jocn.2013.10.040_b0175","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1160\/TH04-02-0093","article-title":"Changes in thrombopoiesis and platelet reactivity in extremely low birth weight infants undergoing erythropoietin therapy for treatment of anaemia of prematurity","volume":"93","author":"Haiden","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jocn.2013.10.040_b0180","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/j.1651-2227.2003.tb00511.x","article-title":"Recombinant human erythropoietin might induce strawberry haemangiomas in very-low-birthweight preterm infants","volume":"92","author":"Zaffanello","year":"2003","journal-title":"Acta Paediatr"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586814000460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586814000460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T01:48:49Z","timestamp":1716515329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586814000460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0967586814000460"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2013.10.040","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotection with erythropoietin in preterm and\/or low birth weight infants","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2013.10.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}